Diabetes Clinical Trials in Denver

Showing 1-20 of 497 trials

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

NCT05018416

The purpose of this study is to assess the safety, efficacy, and durability of up to two Renal Autologous Cell Therapy (REACT) / rilparencel injections delivered percutaneously into biopsied and non-biopsied contralateral kidneys on renal function progression in two different cohorts of subjects with Type1 Diabetes Mellitus (T1DM) or Type2 Diabetes Mellitus(T2DM) and Chronic Kidney Disease (CKD).

Chronic Kidney DiseasesType 1 Diabetes MellitusType 2 Diabetes Mellitus

Prokidney53 participantsStarted Jul 2021

Denver, Colorado, United States • Newark, Delaware, United States • Nampa, Idaho, United States +2 more locations

RECRUITINGPhase 28.4 miles

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321

INHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 10 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of an Afrezza plus BI reigmen on participant and parent/legally authorized representative satisfaction. Participants will be followed for 13 weeks during the main phase followed by an optional Extension Phase for participants continuing to use Afrezza in combination with BI for up to 26 weeks.

Type 1 Diabetes Mellitus

Mannkind Corporation100 participantsStarted Feb 2026

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +7 more locations

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

Diabetes Trials in Other Cities

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Extension Study

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

Other Conditions in Denver